Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A snapshot of COVID-19 infection in patients with solid tumors.
Fuentes-Antrás J, Manzano A, Marquina G, Paz M, Aguado C, Granja M, Benítez J, Ortega J, Priego A, González C, Tejerina-Peces J, Flores P, de Sa AL, Toledano C, Olalla J, de Luna A, Bartolomé J, Pérez-Segura P. Fuentes-Antrás J, et al. Among authors: de luna a, de sa al. Int J Cancer. 2021 May 15;148(10):2389-2397. doi: 10.1002/ijc.33420. Epub 2020 Dec 19. Int J Cancer. 2021. PMID: 33270902 Free PMC article.
Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors.
Fuentes-Antrás J, Martínez-Rodríguez A, Guevara-Hoyer K, López-Cade I, Lorca V, Pascual A, de Luna A, Ramírez-Ruda C, Swindell J, Flores P, Lluch A, Cescon DW, Pérez-Segura P, Ocaña A, Jones F, Moreno F, García-Barberán V, García-Sáenz JÁ. Fuentes-Antrás J, et al. Among authors: de luna a. Int J Mol Sci. 2023 Jul 13;24(14):11419. doi: 10.3390/ijms241411419. Int J Mol Sci. 2023. PMID: 37511178 Free PMC article.
Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study).
González-Santiago S, Saura C, Ciruelos E, Alonso JL, de la Morena P, Santisteban Eslava M, Gallegos Sancho MI, de Luna A, Dalmau E, Servitja S, Ruiz Borrego M, Chacón JI. González-Santiago S, et al. Among authors: de la morena p, de luna a. Breast Cancer Res Treat. 2020 Nov;184(2):469-479. doi: 10.1007/s10549-020-05866-1. Epub 2020 Sep 2. Breast Cancer Res Treat. 2020. PMID: 32876911
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohort.
Sánchez-Bayona R, Lopez de Sa A, Jerez Gilarranz Y, Sanchez de Torre A, Alva M, Echavarria I, Moreno F, Tolosa P, Herrero Lopez B, de Luna A, Lema L, Gamez Casado S, Madariaga A, López-Tarruella S, Manso L, Bueno-Muiño C, Garcia-Saenz JA, Ciruelos E, Martin M. Sánchez-Bayona R, et al. Among authors: de luna a. Breast Cancer Res Treat. 2024 May 4. doi: 10.1007/s10549-024-07324-8. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38703285
Yeast diversity in open agave fermentations across Mexico.
Gallegos-Casillas P, García-Ortega LF, Espinosa-Cantú A, Avelar-Rivas JA, Torres-Lagunes CG, Cano-Ricardez A, García-Acero ÁM, Ruiz-Castro S, Flores-Barraza M, Castillo A, González-Zozaya F, Delgado-Lemus A, Molina-Freaner F, Jacques-Hernández C, Hernández-López A, Delaye L, Aguirre-Dugua X, Kirchmayr MR, Morales L, Mancera E, DeLuna A. Gallegos-Casillas P, et al. Yeast. 2024 Jan;41(1-2):35-51. doi: 10.1002/yea.3913. Epub 2023 Dec 6. Yeast. 2024. PMID: 38054508
158 results